Shopping Cart
- Remove All
Your shopping cart is currently empty
EBVBZLF1 (190-197) is an immunodominant CEF control peptide derived from the Epstein-Barr virus (EBV). It serves as a suitable epitope for CD8+ T cells, facilitating the release of IFNg. The CD8 positive cytotoxic T lymphocytes (CTL) response to EBVBZLF1 (190-197) is diverse, capable of cross-recognizing similar peptide sequences from both host self-proteins and bacterial proteins. This peptide is also utilized in research on autoimmune diseases.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 10 mg | Inquiry | Backorder | |
| 50 mg | Inquiry | Backorder |
| Description | EBVBZLF1 (190-197) is an immunodominant CEF control peptide derived from the Epstein-Barr virus (EBV). It serves as a suitable epitope for CD8+ T cells, facilitating the release of IFNg. The CD8 positive cytotoxic T lymphocytes (CTL) response to EBVBZLF1 (190-197) is diverse, capable of cross-recognizing similar peptide sequences from both host self-proteins and bacterial proteins. This peptide is also utilized in research on autoimmune diseases. |
| Molecular Weight | 1003.24 |
| Formula | C47H82N14O10 |
| Cas No. | 200124-17-0 |
| Sequence | RAKFKQLL |
| Sequence Short | Arg-Ala-Lys-Phe-Lys-Gln-Leu-Leu |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.